The soy isoflavone genistein induces estrogen synthesis in an extragonadal pathway

Molecular and Cellular Endocrinology

Volumn 302, Issue 1, 2009, Pages 73-80

  Ye, Lan ^b   Chan, Ming Y ^b   Leung, Lai K ^a,b  

^a Food and Nutritional Sciences Programme   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aromatase; Estrogen; Gene expression; Genistein; Hepatocytes

Indexed keywords

AROMATASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ESTROGEN; GENISTEIN; ISOFLAVONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHYTOESTROGEN; PROTEIN KINASE C ALPHA;

ARTICLE; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ESTROGEN SYNTHESIS; GONAD; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; SOYBEAN; WESTERN BLOTTING;

AROMATASE; BLOTTING, WESTERN; CELL LINE, TUMOR; ESTROGENS; GENE EXPRESSION REGULATION; GENISTEIN; HUMANS; LIVER; PHYTOESTROGENS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOYBEANS;

EID: 60549108141     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.01.003     Document Type: Article

References (48)

1. Adlercreutz H., Gorbach S.L., Goldin B.R., Woods M.N., Dwyer J.T., and Hamalainen E. Estrogen metabolism and excretion in oriental and Caucasian women. Journal of the National Cancer Institute 86 (1994) 1076-1082
2. Adlercreutz H., Markkanen H., and Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342 (1998) 1209-1210
3. Borradaile N.M., de Dreu L.E., Wilcox L.J., Edwards J.Y., and Huff M.W. Soya phytoestrogens, genistein and daidzein, decrease apolipoproteini B secretion from HepG2 cells through multiple mechanisms. Biochemical Journal 366 (2002) 531-539
4. Brooks J.D., and Thompson L.U. Mammalian lignans and genistein decrease the activities of aromatase and 17β-hydroxysteroid dehydrogenase in MCF-7 cells. The Journal of Steroid Biochemistry and Molecular Biology 94 (2005) 461-467
5. Brueggemeier R.W., Gu X., Mobley J.A., Joomprabutra S., Bhat A.S., and Whetstone J.L. Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosysnthesis, and metabolism. Annals of the New York Academy of Sciences 948 (2001) 51-66
6. Castagnetta L.A., Agostara B., Montalto G., Polito L., Campisi I., Saetta A., Itoh T., Yu B., Chen S., and Carruba G. Local estrogen formation by nontumoral, cirrhotic, and malignant human liver tissues and cells. Cancer Research 63 16 (2003) 5041-5045
7. Colditz G.A. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy. Journal of Women's Health 8 (1999) 347-357
8. Diaz-Cruz E.S., Shapiro C.L., and Brueggemeier R.W. Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 2563-2570
9. Dickson R.B., Kasid A., Huff K.K., Bates S.E., Knabbe C., Bronzert D., et al. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. Proceedings of the National Academy of Sciences of United States of America 84 (1987) 837-841
10. Edmunds K.M., Holloway A.C., Crankshaw D.J., Agarwal S.K., and Foster W.G. The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells. Reproduction, Nutrition, Development 45 (2005) 709-720
11. Eng E.T., Williams D., Mandava U., Kirma N., Tekmal R.R., and Chen S. Suppression of aromatase (estrogen synthetase) by red wine phytochemicals. Breast Cancer Research and Treatment 67 (2001) 133-146
12. Eng E.T., Ye J., Williams D., Phung S., Moore R.E., Young M.K., et al. Suppression of estrogen biosynthesis by procyanidin dimmers in red wine and grape seeds. Cancer Research 63 (2003) 8516-8522
13. Grube B.J., Eng E.T., Kao Y.C., Kwon A., and Chen S. White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation. The Journal of Nutrition 131 (2001) 3288-3293
14. Gunson D., Steele R., and Chau R. Prevention of spontaneous tumors in female rats by fadrozole hydrochloride, an aromatase inhibitor. British Journal of Cancer 72 (1995) 72-75
15. International Agency for Research on Cancer 1999, Hormonal contraception and post-menopausal hormonal therapy. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. vol. 72, Lyon, France.
16. Izumi T., Piskula M.K., Osawa S., Obata A., Tobe K., Saito M., Kataoka S., Kubota Y., and Kikuchi M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. Journal of Nutrition 130 7 (2000) 1695-1699
17. Kao Y.C., Zhou C., Sherman M., Laughton C.A., and Chen S. Molecular basis of the inhibition of human aromatase (estrogen synthtase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environmental Health Perspectives 106 (1998) 85-92
18. Kinoshita Y., and Chen S. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Cancer Research 63 (2003) 3546-3555
19. Kuiper G.G.J.M., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. Endocrinology 139 (1998) 4252-4263
20. Lamon-Fava S. Genistein activates apolipoprotein A-I gene expression in the human hepatoma cell line HepG2. Journal of Nutrition 130 (2000) 2489-2492
21. Lamon-Fava S., and Micherone D. Regulation of apoA-I gene expression: mechanism of action of estrogen and genistein. Journal of Lipid Research 45 (2004) 106-112
22. Lamon-Fava S., Ordovas M., and Schaefer E.J. Estrogen increases apolipoprotein (apo) A-1 secretion in HepG2 cells by modulating transcription of the apoA-1 gene promoter. Arteriosclerosis, Thrombosis, and Vascular Biology 19 (1999) 2960-2965
23. Le Bail J.C., Pouget C., Fagnere C., Basly J.P., Chulia A.J., and Habrioux G. Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities. Life Sciences 68 (2001) 751-761
24. Lee K.M., Abel J., Ko Y., Harth V., Park W.Y., Seo J.S., et al. Genetic polymorphisms of cytochrome P450 19 and 1B1, alcohol use, and breast cancer risk in Korean women. British Journal of Cancer 88 (2003) 675-678
25. Leung L.K., and Wang T.T. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7. British Journal of Cancer 81 (1999) 387-392
26. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Method 25 (2001) 402-408
27. Mayr B., and Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nature Reviews Molecular Cell Biology 2 (2001) 599-609
28. Myllymaki S., Haavisto T., Vainio M., Toppari J., and Paranko J. In vitro effects of diethylstilbestrol, genistein, 4-tert-butylphenol, and 4-tert-octylphenol on steroidogenic activity of isolated immature rat ovarian follicles. Toxicology and Applied Pharmacology 204 (2005) 69-80
29. Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6 (1996) 1-42
30. Pike M.C., and Spicer D.V. The chemoprevention of breast cancer by reducing sex steroid exposure: perspectives from epidemiology. Journal of Cellular Biochemistry Suppl. 17G (1993) 26-36
31. Rice S., Mason H.D., and Whitehead S.A. Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulose-luteal cells. The Journal of Steroid Biochemistry and Molecular Biology 101 (2006) 216-225
32. Scheiber M.D., Liu J.H., Subbiah M.T., Rebar R.W., and Setchell K.D. Dietary inclusion of whole soy foods results in significant reductions in clinical risk factors for osteoporosis and cardiovascular disease in normal postmenopausal women. Menopause 8 5 (2001) 384-392
33. Sebastian S., and Bulun S.E. A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. Journal of Clinical Endocrinology and Metabolism 86 (2001) 4600-4602
34. Sebastian S., Takayama K., Shozu M., and Bulun S.E. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. Molecular Endocrinology 16 (2002) 2243-2254
35. Shin E.S., Cho S.Y., Lee E.H., Lee S.J., Chang I.S., and Lee T.R. Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine. European Journal of Nutrition 45 (2006) 159-164
36. Shin E.S., Lee H.H., Cho S.Y., Park H.W., Lee S.J., and Lee T.R. Genistein downregulates SREBP-1 regulated gene expression by inhibiting site-1 protease expression in HepG2 cells. Journal of Nutrition 137 (2007) 1127-1131
37. Shozu M., Zhao Y., Bulun S.E., and Simpson E.R. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter I.6. Endocrinology 139 (1998) 1610-1617
38. Shutt D.A., and Cox R.I. Steroid and phyto-estrogen binding to sheep Uterine receptors in vitro. The Journal of Endocrinology 52 (1972) 291-310
39. Simpson E.R., and Davis S.R. Minireview: aromatase and the regulation of estrogen biosynthesis-some new perspectives. Endocrinology 142 (2001) 4589-4594
40. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Corbin C.J., and Mendelson C.R. Tissue-specific promoters regulate aromatase cytochrome P450 expression. The Journal of Steroid Biochemistry and Molecular Biology 44 (1993) 321-330
41. Simpson E.R., Zhao Y., Agarwal V.R., Michael M.D., Bulun S.E., Hinshelwood M.M., et al. Aromatase expression in health and disease. Recent Progress in Hormone Research 52 (1997) 185-213 discussion 213-214
42. Toniolo P.G., Levitz M., Zeleniuch-Jacquotte A., Banerjee S., Koenig K.L., Shore R.E., et al. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. Journal of the National Cancer Institute 87 (1995) 190-197
43. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annual Review of Biochemistry 63 (1994) 451-486
44. Wang Y., Lee K.W., Chan F.L., Chen S., and Leung L.K. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicological Sciences 92 (2006) 71-77
45. Wang, Y., Gho, W.M., Chan, F.L., Chen, S., Leung, L.K., in press. The red clover isoflavone biochanin A inhibits aromatase activity and expression. British Journal of Nutrition.
46. Watson C.S., Norfleet A.M., Pappas T.C., and Gametchu B. Rapid actions of estrogens in GH3/B6 pituitary tumour cells via a plasma membrane version of estrogen receptor-alpha. Steroids 64 (1999) 5-13
47. Yoshidome K., Shibata M.A., Couldrey C., Korach K.S., and Green J.E. Estrogen promotes mammary tumour development in C3 (1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumour progression. Cancer Research 60 (2000) 6901-6910
48. Zhang X., Jiao J.J., Bhavnani B.R., and Tam S.P. Regulation of human Apolipoprotein A-1 gene expression by equine estrogens. Journal of Lipid Research 42 (2001) 1789-1800